Traduction de «evaluation of quality data » (Néerlandais → Français) :

This agreement provides for an enhanced collaboration between the two institutions in the evaluation of quality data in applications for MA or associated amendments (variations) for vaccines for veterinary use, “Good Manufacturing Practices” inspection (GMP) and post-marketing reviews (monitoring by the FAMHP on samples taken).
This agreement provides for an enhanced collaboration between the two institutions in the evaluation of quality data in applications for MA or associated amendments (variations) for vaccines for veterinary use, “Good Manufacturing Practices” inspection (GMP) and post-marketing reviews (monitoring by the FAMHP on samples taken).

d) heeft elke gemachtigd gebruiker die over een elektronische identiteitskaart beschikt toegang tot de toepassingen “Shared Artritis File for Electronic Use (SAFE)”, “Raadpleging van de wilsverklaring inzake euthanasie - eutha-consult”, “ORTHOpedic Prosthesis Identification Data - Electronic Registry - ORTHOpride®”, “Project on cancer of the rectum - Central Image Repository (PROCARE RX)”, “Qermid(c)Pacemakers-Quality Electronic Registration of Medical Implant Devices”, “SMUREG”, “Medico-Administratieve Stromen – Thuisverpleging (MEDADM-INF)”, “ZNA - Zorgportaal – SARAi”, “Registratie van Therapeutische Projecten (TherPro – PatientRegistration)”, “Medega”, “QermidDefibrilateur-Quality Electronic Registration of Medical Implant Devices”, “eHealthBox”, “QermidEndoprothèses-Quality Electronic Registration of Medical Implant Devices”, “QermidPacemakers-Quality Electronic Registration of Medical Implant Devices”, “QermidTuteurs Coronaires- Quality Electronic Registration of Medical Implant Devices”, “Registratiemodule van de Belgische Virtuele Tumorbank”, “Catalogus van de Belgische Virtuele Tumorbank”, “CIVARS – Chapter IV Agreement Requesting System”, “Web Application Metahub”, “Raadpleging van medische kaart”, “TDI - Registratie Module van de “Treatment Demand Indicator””, “eShop - Online bestelling getuigschriften voor verstrekte hulp (Medattest)”, “BNMDR - Belgian NeuroMuscular Disease Registry”, “eHealthConsent”, “Moduledatabank Jeugdhulp Vlaanderen” en “Authentieke bron geneesmiddelen”.
d) chaque utilisateur habilité qui dispose d’une Carte d’Identité Electronique a accès aux applications « Shared Artritis File for Electronic Use (SAFE) », « Consultation de la déclaration anticipée d’euthanasie- eutha-consult », « ORTHOpedic Prosthesis Identification Data - Electronic Registry - ORTHOpride® », « Project on cancer of the rectum - Central Image Repository (PROCARE RX) », « Qermid(c)Pacemakers- Quality Electronic Registration of Medical Implant Devices », « SMUREG », « Flux Medico-Administratifs - Infirmier A Domicile (MEDADM-INF) », « ZNA - Zorgportaal – SARAi », « Enregistrement des projets thérapeutiques (TherPro – PatientRegistration) », « Medega », « QermidDefibrilateur-Quality Electronic Registration of Medical Implant Devices », « eHealthBox », « QermidEndoprothèses- Quality Electronic Registration of Medical Implant Devices », « QermidPacemakers- Quality Electronic Registration of Medical Implant Devices », « QermidTuteurs Coronaires-Quality Electronic Registration of Medical Implant Devices », « Module d’enregistrement de la Tumorothèque Virtuelle Belge », « Catalogue de la Tumorothèque Virtuelle Belge », « CIVARS – Chapter IV Agreement Requesting System », « Web Application Metahub », « Consultation des cartes médicales », « TDI

Lecture: Quality of care assessment using GP's electronic patient records : do we need data from home visits ? (.Powerpoint) by Hans Vandenberghe, Scientific Institute of Public Health (IPH), unit of Epidemiology, Brussels (B)
Lecture: Quality of care assessment using GP's electronic patient records (.Powerpoint) : do we need data from home visits ? by Hans Vandenberghe, Scientific Institute of Public Health (IPH), unit of Epidemiology, Brussels (B)

haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.
haemovigilance data and monitoring their implementation ●● The first annual report of the Haemovigilance Centre was published in 2007 Since November 2005, hospitals and blood establishments have been required to report to the Belgian Centre for Haemovigilance of the FAMHP serious reactions during the collection or administration of blood components and serious events relating to the quality or safety of blood components.

Quality evaluator inzake geavanceerde therapieën
Évaluateur Quality en matière de thérapies avancées

The FAMHP is concerned with the evaluation of preclinical and quality aspects of a trial.
The FAMHP is concerned with the evaluation of preclinical and quality aspects of a trial.

The “PRE pillar” is also responsible for the evaluation of the quality, safety and efficacy of the end products.
The “PRE pillar” is also responsible for the evaluation of the quality, safety and efficacy of the end products.

The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.
The evaluation is based on current standards and guidelines on the quality, safety and clinical efficacy of medicines and health products.

An instrument is being set up that aims at ensuring good quality care taking and screening, viz. the Instrument voor Psychosociale Evalutie en Opvang (IPEO) (i.e. the “Instrument for Psychosocial Evaluation and Care”).
Une aide pour une prise en charge et un screening de bonne qualité est en préparation: l’Instrument voor Psychosociale Evaluatie en Opvang (IPEO, Instrument pour l’évaluation et la prise en charge psychosociale).

serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about
serious adverse events associated with the collection, testing, processing, storage and distribution of blood or blood components that may have an effect on their quality or safety ●● Collecting and evaluating information about